WDR70 is a protein implicated in the regulation of complex cellular processes, and its activity can be influenced by a variety of biochemical mechanisms. Certain compounds known to elevate intracellular cyclic AMP (cAMP) levels serve to enhance protein kinase A activity, which in turn, may lead to phosphorylation events that adjust the functional dynamics of WDR70 through modified interactions with other proteins. Simultaneously, the inhibition of phosphodiesterases, which prevents the degradation of cAMP, extends the duration of such signaling, ensuring sustained influence on WDR70's activity. Additionally, agents that increase intracellular calcium concentrations can activate calcium-dependent kinases and phosphatases, which might serve as indirect modulators of WDR70, suggesting that calcium signaling plays a role in sculpting its functional landscape.
Other modulatory tactics involve the use of inhibitors targeting protein phosphatases, which when obstructed, can lead to enhanced phosphorylation of proteins within the cellular milieu, possibly impacting the activity of WDR70 through indirect alterations of its protein complex. The interplay of kinases and phosphatases in maintaining cellular protein phosphorylation states is essential, with non-selective kinase inhibitors potentially triggering compensatory pathways that could inadvertently elevate WDR70 activity. Furthermore, the perturbation of ionic homeostasis via Na+/K+-ATPase inhibitors may lead to secondary signaling events that impact WDR70 functionality. Collectively, these various biochemical strategies underscore the multifaceted nature of cellular signaling networks and demonstrate the indirect but significant potential for chemical compounds to influence the activation state of WDR70.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, preventing cAMP breakdown and thereby prolonging PKA activation. This can impact WDR70 function by sustaining signaling pathways that regulate its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate substrates that may interact with WDR70, influencing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which can modulate calcium-dependent protein kinases and phosphatases, potential regulators of WDR70. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibitor of protein phosphatases PP1 and PP2A, which can lead to increased phosphorylation levels of cellular proteins, potentially affecting WDR70 activity indirectly through changes in its protein complex. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Engages the insulin receptor and can initiate signaling cascades that can indirectly modify WDR70 activity through various downstream pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that raises intracellular calcium levels, possibly affecting WDR70 function through calcium-mediated signaling pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent non-selective protein kinase inhibitor that can lead to the activation of compensatory pathways that may enhance WDR70 activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases (SAPKs) which could lead to the modification of WDR70 activity as a response to cellular stress. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3beta, potentially causing changes in WDR70 activity due to the alteration of Wnt signaling pathway, known to regulate various cellular processes. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Inhibits Na+/K+-ATPase leading to increased intracellular sodium and calcium levels, which may indirectly influence WDR70 function through altered ionic homeostasis and subsequent signaling cascades. | ||||||